Clinical Trials Browser

Phase 4 × Bortezomib × 90 days × Clear all

NCT02844322 2026-02-11

BDH-WM01

Phase 4 Completed

Waldenstrom Macroglobulinemia

NCT07334535 2026-01-13

Isa-VRD in TIE HRMM

Phase 4 Not yet recruiting

Multiple Myeloma